Refractory or Relapsed Solid Tumors
3 clinical trials · Condition
◉ Watch Refractory or Relapsed Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Phase I/II Study of Avelumab in Pediatric Cancer Participants (NCT03451825) | EMD Serono Research & Development Institute, Inc. | 2018-03-07 |
| Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors (NCT01634893) | The University of Texas Health Science Center at San Antonio | 2012-06-01 |
Track Refractory or Relapsed Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.